FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge

Pinto, Gonçalo Sousa; Hung, Matthew; Okoya, Funmbi; Uzman, Nilhan

doi:10.1016/j.sapharm.2020.07.004

Cited by 31 publications

(19 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As the international organization representing pharmacists and pharmaceutical scientists, FIP has taken the lead during this unprecedented time and has produced a number of guidelines to standardise and inform pharmacy practice and education across the globe and provide support to practising pharmacists. 10 , 11 , 12 , 13 Within FIP's six Special Interest Groups (SIGs) is the Pharmacy Practice Research SIG (PPR SIG), which organized a webinar, as part of the FIP series “Responding to the Pandemic Together”, to provide pharmacists with up-to-date information. 14 This commentary presents the recommendations of an expert panel consisting of journal editors in pharmacy as presented here and in this webinar.…”

Section: Time For a Pause?mentioning

confidence: 99%

Pharmacy practice research priorities during the COVID-19 pandemic: Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group

Dawoud

Chen

Rossing

et al. 2021

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

Across the globe, pharmacists on the frontline continue to fight COVID-19 and its continuously evolving physical, mental, and economic consequences armed by their knowledge, professionalism, and dedication. Their need for credible scientific evidence to inform their practice has never been more urgent. Despite the exponentially increasing number of publications since the start of the pandemic, questions remain unanswered, and more are created, than have been resolved by the increasing number of publications. A panel of leading journal editors was convened by the International Pharmaceutical Federation (FIP) Pharmacy Practice Research Special Interest Group to discuss the current status of COVID-19 related research, provide their recommendations, and identify focal points for pharmacy practice, social pharmacy, and education research moving forward. Key priorities identified spanned a wide range of topics, reflecting the need for good quality research to inform practice and education. The panel insisted that a foundation in theory and use of rigorous methods should continue forming the basis of inquiry and its resultant papers, regardless of topic area. From assessing the clinical and cost effectiveness of COVID-19 therapies and vaccines to assessing different models of pharmaceutical services and education delivery, these priorities will ensure that our practice is informed by the best quality scientific evidence at this very challenging time.

show abstract

Section: Time For a Pause?mentioning

confidence: 99%

Pharmacy practice research priorities during the COVID-19 pandemic: Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group

Dawoud

Chen

Rossing

et al. 2021

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

show abstract

“…20 FIP has initiated several approaches, such as disseminating evidence-based information in consultation with global experts, digital response, and policy and practice guidelines for pharmaceutical practice. 21 Australian guidelines for pharmacists regarding COVID-19 align closely with the FIP guidelines. 22 Recently, a commentary paper by Nguy et al (2020) described the contribution of the hospital pharmacist in an Australian hospital toward managing COVID-19 cases.…”

Section: Introductionmentioning

confidence: 85%

Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia

Parajuli

Khanal

Wechkunanukul

et al. 2022

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

The purpose of this paper is to provide an overview of the pharmacy practice and initiatives taken by the Australian federal government to ensure the continued supply of essential medicines under the conditions of an emergency response plan for COVID-19. During the pandemic, Australian pharmacists have been working collaboratively with multidisciplinary teams at the frontline to manage the equitable and safe supply of medicines despite the unprecedented situation. Although these presented problems for small pharmacies, social distancing policies were implemented widely to maintain personal and environmental hygiene and reduce the number of face-to-face patient visits. In collaboration with various pharmaceutical stakeholders, the Australian government responded rapidly to ensure equitable and sufficient supply with continued access to therapeutic goods during the pandemic. Additionally, vital policies and practices have been implemented, including supplying regular medicines at government-subsidized prices, a maximum one-month supply of some prescription medicines and purchase limits on over-the-counter medicines (one unit per purchase), medication management reviews through telehealth, electronic and digital prescribing, home delivery of medicines to vulnerable people and those in home isolation and the provision of serious shortage medicine substitution rights to pharmacists. Pharmacists were encouraged to communicate and collaborate with other local pharmacies to ensure that essential pharmacy services met community needs (e.g., opening hours). However, there has been a shortage of some medicines due to supply chain disruption and increased demand due to the pandemic. Higher demand for flu vaccinations, increased work pressure in pharmacies, and severe frustration and anxiety in pharmacy customers were also reported. Vigilance is required to monitor foreseeable shortages of therapeutics goods, particularly in regional pharmacies. There is an opportunity for long-term change to retain certain rights and roles based on the competence shown by pharmacists in this challenging period, such as telephone medication reviews, telehealth for MedsCheck and Diabetes MedsCheck, digital prescription handling and therapeutic substitution.

show abstract

“…However, from the literature review, it is evident that pharmacist has carried away their responsibilities despite many obstacles like supply shortage, rapidly changing policies, recommendations, treatment design, increased burden on the health system, and also difficulties in direct patients-pharmacists communication due to risk of transmission. In many countries, laws and regulations for the pharmacy practice had been immediately adapted which gave the pharmacists their long due scope and opportunities to serve the patients and to demonstrate that their contribution is valuable to the healthcare system [ 101 ]. Cadogan and Hughes described frameworks for pharmacists in the UK and Canada, where pharmacists can evaluate and manage patients according to the pre-existed formulary and drug scheduling models for their minor ailments during a time of routine check-ups or rounds if physicians are unavailable or reduced [ 27 ].…”

Section: Obstacles To Pharmacy Services During Covid-19 and Future Prmentioning

confidence: 99%

A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future

et al. 2021

View full text Add to dashboard Cite

Background COVID-19, a respiratory tract infection caused by SARS-CoV-2, is a burning question worldwide as it gives rise to a pandemic situation. No specific medications are still recommended for COVID-19; however, healthcare support is crucial for ameliorating the disease condition. Pharmacists are the frontline fighters who are responsible for providing healthcare support to the COVID-19 infected patients around the world. This review endeavored to briefly rationalize the contributions of several pharmacy professionals in diverse fields along with their collaborative efforts and dedication regarding their limitations during the COVID-19 situation and view the prospects of pharmaceutical care services in the post-pandemic period. Main body of the abstract Online databases were utilized to search for scholarly articles and organizational websites, to sum up the information about the contemporary and expanded role of pharmacists. Key articles were retrieved from Google Scholar, PubMed, and Science Direct databases using terms: “COVID-19,” “novel coronavirus,” “community,” “industrial,” “hospital,” “clinical,” “recognition,” “obstacles,” “collaboration,” “SARS-CoV-2,” “healthcare,” and “outbreak” in combination with “pharmacist.” The articles were included from the inception of the pandemic to January 25, 2021. The current review found pharmacist’s global contributions and involvements with other professionals to provide healthcare services amidst COVID-19. This included testing of suspects, providing medical information, psycho-social support, debunking myths, mitigating drug shortage events, telemedicine, e-prescription, infection control, and controlling the drug supply chain. In many countries, pharmacists’ activities were much appreciated but in some countries, they were not properly acknowledged for their contributions amidst COVID-19 outbreak. They played additional roles such as participating in the antimicrobial stewardship team, improving value-added services, conducting clinical data analysis to suppress the outspread of the SARS-CoV-2. Short conclusion During the COVID-19 pandemic while the whole world is fighting against an invisible virus, the pharmacists are the earnest hero to serve their responsibilities along with additional activities. They need to be prepared and collaborate with other healthcare professionals further to meet the challenges of post-pandemic circumstances.

show abstract

FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge

Cited by 31 publications

References 2 publications

Pharmacy practice research priorities during the COVID-19 pandemic: Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group

Pharmacy practice research priorities during the COVID-19 pandemic: Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group

Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia

A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future

Contact Info

Product

Resources

About